GlassScriptPhysician profile
David A Peifer
NPI 1427543156
$10,357.18
in general payments reported to CMS, 2019-2025
24 companies · $641 in 2025
The $641 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,697 · 2020: $953 · 2021: $1,465 · 2022: $936 · 2023: $2,737 · 2024: $1,929 · 2025: $641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,003 · Food and Beverage: $2,303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,003.36 |
| Food and Beverage | $2,302.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,461.38 | 2019-2025 | Tactra, General - Erectile Dysfunction, Ams 700 |
| Olympus Corporation of The Americas | $758.98 | 2019-2020 | |
| Axonics, INC. | $434.00 | 2020-2024 | Axonics |
| Medtronic USA, INC. | $404.21 | 2019-2020 | |
| Coloplast Corp | $377.21 | 2021 | |
| Olympus America INC. | $328.62 | 2019-2021 | |
| Teleflex LLC | $293.15 | 2021-2024 | Urolift |
| Procept Biorobotics Corporation | $250.89 | 2020-2024 | Aquabeam System |
| Cook Medical LLC | $214.22 | 2019-2023 | Resonance |
| Neotract INC. | $190.30 | 2019-2020 | |
| Medtronic, INC. | $180.08 | 2021-2022 | |
| Photocure INC | $164.78 | 2021 | |
| Ge Healthcare | $162.07 | 2025 | |
| Myovant Sciences INC. | $158.53 | 2021-2022 | |
| Immunitybio, INC. | $144.44 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $142.99 | 2022-2025 | Erleada |
| Myriad Genetic Laboratories, INC. | $140.48 | 2021 | |
| Avanos Medical | $138.78 | 2023 | On-Q* Pump and Accessories |
| Smith+Nephew, INC. | $133.14 | 2019 | |
| Urogen Pharma, INC. | $93.78 | 2022 | |
| Dendreon Pharmaceuticals LLC | $92.45 | 2025 | Provenge |
| Sumitomo Pharma America, INC. | $50.45 | 2023-2024 | Gemtesa |
| Abbvie INC. | $23.59 | 2023 | |
| 180 Medical, INC. | $18.66 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Peifer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.